BRKR

Bruker Corp

• Dow Jones·4d ago

  Bruker Is Maintained at Buy by Guggenheim

• Dow Jones·06/24 14:37

  Bruker Is Maintained at Overweight by Barclays

• Reuters·06/24 10:31

  BRUKER <BRKR.O>: BARCLAYS RAISES TARGET PRICE TO $60 FROM $53

• Reuters·06/24 06:56

  U.S. RESEARCH ROUNDUP-Bank of America, FedEx, JPMorgan

• PUBT·06/16 20:15

  Bruker Nano President Mark Munch disposes of 2,000 Bruker shares worth $109,520

• Reuters·06/12 20:16

  BRUKER CORP: FILES FOR MIXED SHELF OFFERING, SIZE NOT DISCLOSED - FILING

• Seeking Alpha·06/09 15:41

  Citrini sees new upside in healthcare stocks, updates basket

• PUBT·06/09 12:04

  Quanterix names Jason Faessler CFO effective June 22

• Dow Jones·06/08 15:24

  Bruker Price Target Raised to $65.00/Share From $55.00 by JP Morgan

• Dow Jones·06/08 15:24

  Bruker Is Maintained at Overweight by JP Morgan

• TipRanks·06/08 11:38

  Bruker price target raised to $65 from $45 at JPMorgan

• TipRanks·06/04 11:17

  Bruker showcases microbiology, infection diagnostics portfolio at ASM meeting

• PUBT·06/04 11:02

  Bruker showcases expanding infection diagnostics portfolio at ASM Microbe 2026

• Seeking Alpha·06/02 14:10

  These 10 mid-cap U.S. healthcare companies carry the market's most expensive valuations

• Reuters·06/02 12:53

  BRUKER CORPORATION <BRKR.O>: BOFA GLOBAL RESEARCH RAISES PRICE OBJECTIVE TO $65 FROM $49